C-reactive protein, inflammation, and coronary risk

Medical Clinics of North America

Volumn 84, Issue 1, 2000, Pages 149-161

  Morrow, David A ^a,b   Ridker, Paul M ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; PRAVASTATIN;

ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DISEASE MARKER; HEART INFARCTION; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0033967794     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70211-X     Document Type: Article

References (84)

1. J.A. Ambrose S.L. Winters A. Stern Angiographic morphology and the pathogenesis of unstable angina pectoris J Am Coll Cardiol 5 1985 609 616
2. E.P. Amento N. Ehsani H. Palmer Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells Arterioscler Thromb 11 1991 1223 1230
3. N.M. Aqel R.Y. Ball H. Waldmann Monocytic origin of foam cells in human atherosclerotic plaques Atherosclerosis 53 1984 265 271
4. B.C. Berk W.S. Weintraub R.W. Alexander Elevation of C-reactive protein in “active” coronary artery disease Am J Cardiol 65 1990 168 172
5. L.M. Biasucci A. Vitelli G. Liuzzo Elevated levels of interleukin-6 in unstable angina Circulation 94 1996 874 877
6. Bini A. Fenoglio J.J. Jr R. Mesa-Tejada Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis: Use of monoclonal antibodies Arteriosclerosis 9 1989 109 121
7. J.J. Boyle Association of coronary plaque rupture and atherosclerotic inflammation J Pathol 181 1997 93 99
8. P. Constantinides Plaque fissuring in human coronary thrombosis J Atheroscler Res 6 1966 1 17
9. A. Corsini F. Bernini P. Quarato Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors Cardiology 87 1996 458 468
10. Cybulsky M.I. Gimbrone M.A. Jr Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis Science 251 1991 788 791
11. M.J. Davies A macro and micro view of coronary vascular insult in ischemic heart disease Circulation 82 1990 II38 II46
12. M.J. Davies A.C. Thomas Plaque fissuring—the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina Br Heart J 53 1985 363 373
13. E. Falk Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi Br Heart J 50 1983 127 134
14. E. Falk Why do plaques rupture? Circulation 86 1992 III30 III42
15. V. Fuster A. Lewis Conner Memorial Lecture. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology Circulation 90 1994 2126 2146
16. Z.S. Galis M. Muszynski G.K. Sukhova Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion Circ Res 75 1994 181 189
17. Z.S. Galis G.K. Sukhova M.W. Lark Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
18. S. Glagov C. Zarins D.P. Giddens Hemodynamics and atherosclerosis: Insights and perspectives gained from studies of human arteries Arch Pathol Lab Med 112 1988 1018 1031
19. K.W. Gong G.Y. Zhu L.H. Wang Effect of active oxygen species on intimal proliferation in rat aorta after arterial injury J Vasc Res 33 1996 42 46
20. F. Haverkate S.G. Thompson S.D. Pyke Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group Lancet 349 1997 462 466
21. R.O. Hynes D.D. Wagner Genetic manipulation of vascular adhesion molecules in mice J Clin Invest 98 1996 2193 2195
22. U. Ikeda M. Ikeda T. Oohara Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner Am J Physiol 260 1991 H1713 H1717
23. J.H. Ip V. Fuster L. Badimon Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation J Am Coll Cardiol 15 1990 1667 1687
24. W. Koenig M. Sund M. Froehlich C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring trends and determinants in cardiovascular disease) Augsberg Cohort Study, 1984 to 1992 Circulation 99 1999 237 242
25. K. Kohchi S. Takebayashi T. Hiroki Significance of adventitial inflammation of the coronary artery in patients with unstable angina: Results at autopsy Circulation 71 1985 709 716
26. L.H. Kuller R.P. Tracy J. Shaten Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial Am J Epidemiol 144 1996 537 547
27. S. Kurakata M. Kada Y. Shimada Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro Immunopharmacology 34 1996 51 61
28. T. Ledue D. Weiner J. Sipe Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum Ann Clin Biochem 35 1998 745 753
29. R.T. Lee P. Libby The unstable atheroma Arterioscler Thromb Vasc Biol 17 1997 1859 1867
30. F. Liao A. Andalibi J.H. Qiao Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice J Clin Invest 94 1994 877 884
31. P. Libby Molecular bases of the acute coronary syndromes Circulation 91 1995 2844 2850
32. P. Libby S.J. Warner G.B. Friedman Interleukin 1: A mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids J Clin Invest 81 1988 487 498
33. P. Libby S.J. Warner R.N. Salomon Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma N Engl J Med 318 1988 1493 1498
34. F. Mach U. Schonbeck J.Y. Bonnefoy Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor Circulation 96 1997 396 399
35. F. Mach U. Schonbeck G.K. Sukhova Reduction of atherosclerosis in mice by inhibition of CD40 signalling Nature 394 1998 200 203
36. E. Macy T. Hayes R. Tracy Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference interval and epidemiologic applications Clin Chem 43 1997 52 58
37. A. Mantovani F. Bussolino E. Dejana Cytokine regulation of endothelial cell function FASEB J 6 1992 2591 2599
38. A. Maseri L.M. Biasucci G. Liuzzo Inflammation in ischaemic heart disease BMJ 312 1996 1049 1050
39. M.A. Mendall P. Patel L. Ballam C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study BMJ 312 1996 1061 1065
40. M.J. Mitchinson R.Y. Ball Macrophages and atherogenesis Lancet 2 1987 146 148
41. P.R. Moreno V.H. Bernardi J. Lopez-Cuellar Macrophages, smooth muscle cells, and tissue factor in unstable angina: Implications for cell-mediated thrombogenicity in acute coronary syndromes Circulation 94 1996 3090 3097
42. P.R. Moreno E. Falk I.F. Palacios Macrophage infiltration in acute coronary syndromes: Implications for plaque rupture Circulation 90 1994 775 778
43. D. Morrow P. Ridker Inflammation in cardiovascular disease Topol E. Textbook of Cardiovascular Medicine Updates 1999 Lippincott-Williams & Wilkins Cedar Knolls
44. E. Munro M. Patel P. Chan Inhibition of human vascular smooth muscle cell proliferation by lovastatin: The role of isoprenoid intermediates of cholesterol synthesis Eur J Clin Invest 24 1994 766 772
45. T. Nagel N. Resnick W.J. Atkinson Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells J Clin Invest 94 1994 885 891
46. Y. Nakashima E. Raines A. Plump Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse Arterioscler Thromb Vasc Biol 18 1998 842 851
47. M. Navab S.Y. Hama T.B. Nguyen Monocyte adhesion and transmigration in atherosclerosis Coron Artery Dis 5 1994 198 204
48. Neri Serneri G. R. Abbate A. Gori Transient intermittent lymphocyte activation is responsible for the instability of angina Circulation 86 1992 790 797
49. L. Osborne Leukocyte adhesion to endothelium in inflammation Cell 62 1990 3 6
50. L. Osborne C. Hession R. Tizard Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced protein that binds to lymphocytes Cell 59 1989 1203 1211
51. M.B. Pepys M.L. Baltz Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein Adv Immunol 34 1983 141 212
52. R.N. Poston D.O. Haskard J.R. Coucher Expression of intercellular adhesion molecule-1 in atherosclerotic plaques Am J Pathol 140 1992 665 673
53. E.W. Raines S.K. Dower R. Ross Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA Science 243 1989 393 396
54. P.D. Richardson M.J. Davies G.V. Born Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques Lancet 2 1989 941 944
55. P. Ridker J. Buring J. Shih Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women Circulation 98 1998 731 733
56. P. Ridker M. Cushman M. Stampfer Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease Circulation 97 1998 425 428
57. P. Ridker R. Glynn C. Hennekens C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction Circulation 97 1998 2007 2011
58. P. Ridker P. Haughie Prospective studies of C-reactive protein as a risk factor for cardiovascular disease J Investig Med 46 1998 391 395
59. P.M. Ridker M. Cushman M.J. Stampfer Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
60. P.M. Ridker C.H. Hennekens B. Roitman-Johnson Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men Lancet 351 1998 88 92
61. P.M. Ridker J.E. Manson J.E. Buring Homocysteine and risk of cardiovascular disease among postmenopausal women JAMA 281 1999 1817 1821
62. P. Ridker N. Rifai M. Pfeffer Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels Circulation 98 1998 839 844
63. P. Ridker N. Rifai M. Pfeffer Long-term effects of pravastatin on plasma concentration of C-reactive protein Circulation 100 1999 230 235
64. W.C. Roberts L.M. Buja The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction: A study of 107 necropsy patients Am J Med 52 1972 425 443
65. G. Rogler K.J. Lackner G. Schmitz Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro Am J Cardiol 76 1995 114A 116A
66. R.S. Rosenson C.C. Tangney Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction JAMA 279 1998 1643 1650
67. R. Ross Atherosclerosis—an inflammatory disease N Engl J Med 340 1999 115 126
68. H.G. Rus R. Vlaicu F. Niculescu Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall Atherosclerosis 127 1996 263 271
69. P. Saren H.G. Welgus P.T. Kovanen TNF-alpha and IL-1 beta selectively induce expression of 92-kDa gelatinase by human macrophages J Immunol 157 1996 4159 4165
70. S.M. Schwartz M.A. Reidy Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension Hum Pathol 18 1987 240 247
71. H. Shimokawa A. Ito Y. Fukumoto Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo: The role of platelet-derived growth factor J Clin Invest 97 1996 769 776
72. H.C. Stary Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults Arteriosclerosis 9 1989 I19 I32
73. D. Steinberg Antioxidants and atherosclerosis: A current assessment Circulation 84 1991 1420 1425
74. D. Steinberg S. Parthasarathy T.E. Carew Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 1989 915 924
75. D.A. Sukovich K. Kauser F.D. Shirley Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: Inhibition by 17beta-estradiol Arterioscler Thromb Vasc Biol 18 1998 1498 1505
76. R. Tracy Inflammation in cardiovascular disease: Cart, horse, or both? Circulation 97 1998 2000 2002
77. R. Tracy R. Lemaitre B. Psaty Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular Health Study and the Rural Health Promotion Project Arterioscler Thromb Vasc Biol 17 1997 1121 1127
78. van der Wal A.C. A.E. Becker van der Loos C.M. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology Circulation 89 1994 36 44
79. C.J. Vaughan M.B. Murphy B.M. Buckley Statins do more than just lower cholesterol Lancet 348 1996 1079 1082
80. J.N. Wilcox K.M. Smith S.M. Schwartz Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque Proc Natl Acad Sci U S A 86 1989 2839 2843
81. J. Wilkins R. Gallimore E. Moore Rapid automated high sensitivity enzyme immunoassay of C-reactive protein Clin Chem 44 1998 1358 1361
82. J.T. Willerson P. Golino J. Eidt Specific platelet mediators and unstable coronary artery lesions: Experimental evidence and potential clinical implications Circulation 80 1989 198 205
83. J.A. Winkles R. Friesel W.H. Burgess Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor) Proc Natl Acad Sci USA 84 1987 7124 7128
84. S. Yla-Herttuala W. Palinski M.E. Rosenfeld Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man J Clin Invest 84 1989 1086 1095